Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
基本信息
- 批准号:8115124
- 负责人:
- 金额:$ 39.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAddressAffectAffinityAlzheimer&aposs DiseaseAnti-Retroviral AgentsAntioxidantsAstrocytesAutopsyBrainCategoriesCellsCellular StressChaperone GeneChronicCognitiveCystineDataDegradation PathwayDementiaDrug Delivery SystemsDrug usageEndoplasmic ReticulumExcitatory NeurotoxinsExhibitsGlutamate TransporterGlutamatesGoalsHIVHighly Active Antiretroviral TherapyHomeostasisIn VitroIndividualInfiltrationInflammatoryInositolLeadLinkMediatingMediator of activation proteinMicrogliaMotorNeuraxisNeurodegenerative DisordersNeuronal DysfunctionNeuronal InjuryNeuronsOxidative StressPancreasParkinson DiseasePathogenesisPathway interactionsPatientsPharmaceutical PreparationsPhosphotransferasesPlayPrevalenceReactive Oxygen SpeciesRoleSignal PathwayTherapeuticTherapeutic AgentsTransactivationViralViral ProteinsVirus Diseasesactivating transcription factoractivating transcription factor 1antiporterattenuationbiological adaptation to stressbrain tissuecentral nervous system injurydesignexcitotoxicityin vivoinjuredmacrophagemacrophage productmonocyteneuron lossneuronal survivalneuropathologyneuroprotectionneurotoxicneurotoxicitynoveloxidative damagepromoterprotein degradationresponsestressor
项目摘要
DESCRIPTION (provided by applicant): Despite the introduction of highly active antiretroviral therapy (HAART), the prevalence of human immunodeficiency virus associated dementia (HAD) has been steadily increasing. Neuronal injury and loss in HAD is initiated by HIV-infected, activated macrophage/microglia via soluble neurotoxic mediators including reactive oxygen species (ROS), excitotoxins, and other metabolites as well as viral proteins. These mediators, which induce oxidative stress, are known to injure neurons directly and alter astrocytic homeostatic functions such as glutamate homeostasis which can lead to excitotoxic neuronal injury. Importantly, several studies in vitro and in vivo have shown that oxidative stress and excitotoxicity are likely critical mechanisms of pathogenesis in HAD. How neurons and astrocytes respond to oxidative stress in HIV infection of the central nervous system (CNS) is largely undefined and underexplored. A major downstream response to oxidative stress is induction of the recently described integrated stress response (ISR) which may be the critical link between oxidative stress and excitotoxicity. Activation of the ISR results in translational attenuation, transactivation of ER chaperone gene promoters, activation of protein degradation pathways and activation of the endogenous antioxidant response. Induction of these responses is regulated by one or more of three distinct signaling pathways: pancreatic endoplasmic reticulum kinase (PERK), IRE1 alpha, and ATF6. Whether one or all of these pathways are induced in neuronal or astrocytic cells during HIV induced CNS injury is not known; however, we have demonstrated that supernatants from HIV infected monocyte derived macrophages (HIV-M/M) induce several components of the ISR including PERK in primary astrocytes in vitro. In addition, we have found that several antiretroviral drugs used in HAART also induce ISR in primary astrocytes. Thus, we hypothesize that that activation of the ISR in astrocytes by HIV M/M and/or HAART exposure is a major determinant of neuronal injury/survival in HAD. Our goal is to determine the role of ISR activation in astrocytes by HIV M/M and HAART therapeutics in mediating neuronal damage in vitro and in vivo in HAD. To do this we will: 1) Determine the mechanism by which ISR activation triggered by HIV-M/M supernatants impacts astrocyte neuroprotective functions and survival, 2) Define the role of HAART drugs in ISR activation in astrocytes, and 3) Define and validate the contribution of chronic activation of the ISR pathways in HAD. By investigating the role of ISR, we expect to uncover a novel mechanism for neuronal dysfunction and loss in HIVE and elucidate the impact of current HAART therapeutics on astrocytic mediated neuronal survival. Patients with HIV associated dementia have increased cellular stress in their brain due to inflammatory infiltration and oxidative stress. These stressors are known activate a protective pathway called the integrated stress response in non-neural cells. This proposal aims to assess the state of activation of the integrated stress response in astrocytes exposed to HIV-infected macrophage products and highly active antiretroviral therapeutic agents and determine the impact of such activation on neuronal survival.
描述(由申请人提供):尽管引入了高效抗逆转录病毒治疗(HAART),但人类免疫缺陷病毒相关性痴呆(HAD)的患病率一直在稳步上升。HAD中的神经元损伤和损失由HIV感染的活化的巨噬细胞/小胶质细胞通过可溶性神经毒性介质(包括活性氧(ROS)、兴奋性毒素和其他代谢物以及病毒蛋白)启动。已知这些诱导氧化应激的介质直接损伤神经元并改变星形胶质细胞稳态功能,例如谷氨酸稳态,这可导致兴奋性毒性神经元损伤。重要的是,一些体外和体内研究表明,氧化应激和兴奋毒性可能是HAD发病机制的关键机制。神经元和星形胶质细胞如何对中枢神经系统(CNS)HIV感染中的氧化应激做出反应在很大程度上是不确定的,也未充分探索。氧化应激的一个主要下游反应是诱导最近描述的综合应激反应(ISR),这可能是氧化应激和兴奋性毒性之间的关键联系。ISR的激活导致翻译减弱、ER伴侣基因启动子的反式激活、蛋白质降解途径的激活和内源性抗氧化反应的激活。这些反应的诱导受三种不同信号通路中的一种或多种调节:胰腺内质网激酶(PERK)、IRE 1 α和ATF 6。在HIV诱导的CNS损伤过程中,是否在神经元或星形胶质细胞中诱导了一种或所有这些途径尚不清楚;然而,我们已经证明,HIV感染的单核细胞衍生的巨噬细胞(HIV-M/M)的上清液诱导了ISR的几种组分,包括体外原代星形胶质细胞中的PERK。此外,我们发现HAART中使用的几种抗逆转录病毒药物也诱导原代星形胶质细胞ISR。因此,我们假设,在星形胶质细胞中的ISR的激活由HIV M/M和/或HAART暴露是HAD中神经元损伤/存活的主要决定因素。我们的目标是确定ISR激活的作用,在星形胶质细胞的HIV M/M和HAART治疗介导的神经元损伤在体外和体内的HAD。为此,我们将:1)确定由HIV-M/M上清液触发的ISR活化影响星形胶质细胞神经保护功能和存活的机制,2)确定HAART药物在星形胶质细胞中ISR活化中的作用,和3)确定和验证HAD中ISR通路的慢性活化的贡献。通过研究ISR的作用,我们期望揭示HIVE中神经元功能障碍和损失的新机制,并阐明当前HAART治疗对星形胶质细胞介导的神经元存活的影响。由于炎症浸润和氧化应激,HIV相关性痴呆患者的大脑中细胞应激增加。已知这些应激源激活非神经细胞中称为整合应激反应的保护途径。该提案旨在评估暴露于HIV感染的巨噬细胞产物和高活性抗逆转录病毒治疗剂的星形胶质细胞中的综合应激反应的激活状态,并确定这种激活对神经元存活的影响。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly L Jordan-Sciutto其他文献
Kelly L Jordan-Sciutto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly L Jordan-Sciutto', 18)}}的其他基金
Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS
大麻素、HIV 和 ART 对中枢神经系统的细胞间和细胞内影响
- 批准号:
10452486 - 财政年份:2020
- 资助金额:
$ 39.38万 - 项目类别:
Inter- and Intra-cellular effects of cannabinoids, HIV and ART in the CNS
大麻素、HIV 和 ART 对中枢神经系统的细胞间和细胞内影响
- 批准号:
10618933 - 财政年份:2020
- 资助金额:
$ 39.38万 - 项目类别:
Role of PERK haplotypes in HIV-Associated Neurocognitive Disorders
PERK 单倍型在 HIV 相关神经认知障碍中的作用
- 批准号:
9317357 - 财政年份:2016
- 资助金额:
$ 39.38万 - 项目类别:
RNA:RNA binding protein complexes in neurons and SIV encephalitis
RNA:神经元和 SIV 脑炎中的 RNA 结合蛋白复合物
- 批准号:
8937093 - 财政年份:2015
- 资助金额:
$ 39.38万 - 项目类别:
Novel Pathways of HAARTmediated Neuronal Toxicity in the Central Nervous System
HAART介导中枢神经系统神经元毒性的新途径
- 批准号:
7492484 - 财政年份:2009
- 资助金额:
$ 39.38万 - 项目类别:
Novel Pathways of HAARTmediated Neuronal Toxicity in the Central Nervous System
HAART介导中枢神经系统神经元毒性的新途径
- 批准号:
7826669 - 财政年份:2009
- 资助金额:
$ 39.38万 - 项目类别:
Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
- 批准号:
7417736 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
- 批准号:
7900322 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
Effects of the Integrated Stress Response in HIV Associated Dementia
综合应激反应对 HIV 相关痴呆的影响
- 批准号:
7661396 - 财政年份:2007
- 资助金额:
$ 39.38万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant